Appointments

  • Ming Tang announces departure from NHS England

    By Curtis Grainge Leadership in the NHS is rarely loud, often thankless, and almost always tested in moments of uncertainty. It is defined less by announcements than by endurance: the ability to hold a steady course while institutions shift, pressures mount and expectations continue to rise.   Against that backdrop, Ming Tang, Chief [...]

  • CluePoints appoints chief people officer to drive global growth

    CluePoints, provider of leading statistical and AI-driven software solutions, has appointed Sinead Godkin as its new chief people officer (CPO). With deep experience scaling global technology organisations through periods of rapid growth, Godkin will lead CluePoints’ people strategy as the company enters its next stage of expansion. Godkin brings senior leadership experience from some of [...]

  • Gifthealth announces Jeremy Richardson as new chief commercial officer

    Gifthealth has announced the appointment of Jeremy Richardson as its new Chief Commercial Officer (CCO). Richardson brings nearly two decades of leadership experience in sales, marketing, trade, and business development across some of the most respected organizations in healthcare. Most recently, he served as Vice President of Strategy & Commercial Growth at Elevance Health. Richardson [...]

  • StuffThatWorks appoints Julie A. Ross as CEO and president

    StuffThatWorks has announced that Julie A. Ross, former CEO of global CRO Advanced Clinical, has joined the company as Chief Executive Officer and president, effective immediately. Ross will lead the company’s next phase of growth as it scales its proprietary patient-derived AI model designed to address the most persistent constraint in pharmaceutical development: lack of [...]

  • Ergéa Group appoints David Rolfe as new Group Chief Executive Officer

    Ergéa, a leading pan-European healthcare company specialising in diagnostic imaging and cancer care, has appointed David Rolfe as Group CEO and named Mark Graves as CEO of Ergéa UK. Effective 24 November 2025, David Rolfe, the outgoing CEO of Ergéa UK, has been appointed CEO of Ergéa Group. As part of this leadership transition, Mark [...]

  • FINN Partners appoints Sophie Taylor-Roberts as Managing Partner and UK Health Group Lead

    Global integrated marketing and communications agency FINN Partners has appointed Sophie Taylor-Roberts as Managing Partner and UK Health Group Lead. Taylor-Roberts will lead the FINN UK Health Group in strengthening its reputation as a leading communications partner for the biopharma, medical device and health system sectors. She succeeds Julie Adrian, who returned to her role [...]

  • FINN appoints industry leader to accelerate growth of its UK Health Group

    Global marketing and communications agency FINN Partners has appointed Julie Adrian as Managing Partner and UK Health Group Lead. In the newly created position, Adrian will report to Gil Bashe, Chair FINN Global Health and Purpose. She will also work closely with Fern Lazar, managing partner, FINN Global Health Practice Lead, and Chantal Bowman-Boyles, managing [...]

  • HealthBook+ steps up personalisation and digital care drive with new advisory board

    AI-powered, digital health platform HealthBook+, which empowers users to take ownership of their own health through guidance and early identification of conditions, has announced a new medical advisory board. The board brings together specialist clinicians with experience and expertise in a broad range of key fields including mental and behavioural health, paediatrics, concierge medicine, direct primary care, [...]

  • Swedish biotech firm AAX gets new CEO

    Biotech company AAX Biotech, specialising in innovative, patentable technologies for improving antibody-based medicines, has appointed Maria Lisa Knudsen as CEO. The appointment is expected to contribute to the company's growth and the development of its pioneering technologies. AAX Biotech is a Swedish startup biotech company aiming to solve unmet needs in developing next-generation antibody therapeutics. [...]

  • Colin Bower joins VivoSense as CEO

    VivoSense, Inc. has announced the appointment of Colin Bower as CEO and a member of its Board of Directors. Bower will succeed Dudley Tabakin, who will continue with VivoSense as Chief Product Officer. VivoSense is an aend-to-end scientific solutions company developing novel digital endpoints from wearable sensor data. Bower said: “I’m delighted to join the [...]

Promotional banner for Health Tech World Live: The future of healthcare AI event at Queen Elizabeth Olympic Park, London, Friday 21 August, 12–4pm. Book now button visible, bright teal accents.